Print   

Wednesday 14 January, 2009

NeutraHealth Plc

Board Change

RNS Number : 6467L
NeutraHealth Plc
14 January 2009
 



14 January 2009 


NEUTRAHEALTH PLC ('the Company')


BOARD CHANGE


 

NeutraHealth plc, one of the UK's leading vitamin & supplement companies, today announces the following changes to the Company's Board. 


Michael Toxvaerd, having supported the transition of executive responsibility to Ray Myers, is standing down as Deputy Chairman with immediate effect due to other commitments. Michael will remain as an advisor to the Board for at least a further 6 months. 


Michael has been instrumental in the development of NeutraHealth; he jointly founded the company in November 2004, taking it to flotation in February 2005 and was Chief Executive for over three years. In June 2008, Michael became Deputy Chairman on the acquisition of Perrigo UK Limited and the appointment of Ray Myers as Chief Executive.



Sir Gulam Noon, Non-Executive Director, commented:

 

'It is Michael's vision and energy that created NeutraHealth and built it into the leading company that it is today. His commitment to the success of the Company has been extraordinary. On behalf of the Board, I thank Michael for his outstanding contribution to the Company, and offer him sincere good wishes for the future.



Enquiries: 


NeutraHealth plc


Ray Myers, CEO 

07768 940 630

Robin Hilton, Finance Director    

07738 018 411



Cenkos (Nominated Adviser and Broker)


Stephen Keys

020 7397 8900



Pelham Public Relations


Kate Catchpole

020 7743 6678



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGUUMWGUPBGAC

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.